cupure logo
trumpgazadealtradekilledaidtrade dealtalksisraeltrain

The one, big unanswered question about Ozempic

The one, big unanswered question about Ozempic
We are nearing a point of no return for GLP-1 drugs. More than one in 10 Americans have already taken a GLP-1 agonist, be it Ozempic, Wegovy or Mounjaro. The medications, originally developed for diabetes treatment, have proven to be remarkably effective in helping people lose weight — and America is in the throes of […]

Comments

World news